Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy
Status:
Recruiting
Trial end date:
2027-05-31
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to determine if adjuvant apalutamide in prostate
cancer patients at high risk of developing subsequent metastatic disease results in prolonged
biochemically recurrence-free survival after radical prostatectomy (RPE) in comparison to
standard of care (SOC).